Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity

Nikoletta Lendvai; Ioanna Tsakos; Sean M. Devlin; Wendy L. Schaffer; Hani Hassoun; Alexander M. Lesokhin; Heather Landau; Neha Korde; Sham Mailankody; Eric Smith; David J. Chung; Guenther Koehne; Gunjan L. Shah; Aeri Alexander; Minal Patel; Andrea Ballagi; Ida Grundberg; Sergio A. Giralt; Ola Landgren

doi:10.1080/10428194.2017.1403020

Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity

Nikoletta Lendvai, Ioanna Tsakos, Sean M. Devlin, Wendy L. Schaffer, Hani Hassoun, Alexander M. Lesokhin, Heather Landau, Neha Korde, Sham Mailankody, Eric Smith, David J. Chung, Guenther Koehne, Gunjan L. Shah, Aeri Alexander, Minal Patel, Andrea Ballagi, Ida Grundberg, Sergio A. Giralt, Ola Landgren

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Leukemia & Lymphoma
DOIs	https://doi.org/10.1080/10428194.2017.1403020
State	Published - Jan 8 2018

Disciplines

Pharmacology
Medicine and Health Sciences
Endocrinology, Diabetes, and Metabolism

Access to Document

10.1080/10428194.2017.1403020License: Unspecified

Cite this

Lendvai, N., Tsakos, I., Devlin, S. M., Schaffer, W. L., Hassoun, H., Lesokhin, A. M., Landau, H., Korde, N., Mailankody, S., Smith, E., Chung, D. J., Koehne, G., Shah, G. L., Alexander, A., Patel, M., Ballagi, A., Grundberg, I., Giralt, S. A., & Landgren, O. (2018). Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity. Leukemia & Lymphoma. https://doi.org/10.1080/10428194.2017.1403020

Lendvai, N, Tsakos, I, Devlin, SM, Schaffer, WL, Hassoun, H, Lesokhin, AM, Landau, H, Korde, N, Mailankody, S, Smith, E, Chung, DJ, Koehne, G, Shah, GL, Alexander, A, Patel, M, Ballagi, A, Grundberg, I, Giralt, SA & Landgren, O 2018, 'Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity', Leukemia & Lymphoma. https://doi.org/10.1080/10428194.2017.1403020

@article{fa4170ca22a148bdbee12f946c318622,

title = "Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity",

author = "Nikoletta Lendvai and Ioanna Tsakos and Devlin, {Sean M.} and Schaffer, {Wendy L.} and Hani Hassoun and Lesokhin, {Alexander M.} and Heather Landau and Neha Korde and Sham Mailankody and Eric Smith and Chung, {David J.} and Guenther Koehne and Shah, {Gunjan L.} and Aeri Alexander and Minal Patel and Andrea Ballagi and Ida Grundberg and Giralt, {Sergio A.} and Ola Landgren",

year = "2018",

month = jan,

day = "8",

doi = "10.1080/10428194.2017.1403020",

language = "American English",

journal = "Leukemia & Lymphoma",

}

TY - JOUR

T1 - Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity

AU - Lendvai, Nikoletta

AU - Tsakos, Ioanna

AU - Devlin, Sean M.

AU - Schaffer, Wendy L.

AU - Hassoun, Hani

AU - Lesokhin, Alexander M.

AU - Landau, Heather

AU - Korde, Neha

AU - Mailankody, Sham

AU - Smith, Eric

AU - Chung, David J.

AU - Koehne, Guenther

AU - Shah, Gunjan L.

AU - Alexander, Aeri

AU - Patel, Minal

AU - Ballagi, Andrea

AU - Grundberg, Ida

AU - Giralt, Sergio A.

AU - Landgren, Ola

PY - 2018/1/8

Y1 - 2018/1/8

UR - https://www.tandfonline.com/doi/full/10.1080/10428194.2017.1403020

U2 - 10.1080/10428194.2017.1403020

DO - 10.1080/10428194.2017.1403020

M3 - Article

JO - Leukemia & Lymphoma

JF - Leukemia & Lymphoma

ER -

Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity

Disciplines

Access to Document

Other files and links

Cite this